Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Testosterone and Growth Hormone for Bone Loss in Men
This study is ongoing, but not recruiting participants.
Study NCT00080483 Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
First Received: April 5, 2004 Last Updated: April 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypopituitarism
Hypogonadism
Growth Hormone Deficiency
Additional conditions recognized in this trial
Dwarfism, Pituitary
Endocrine System Diseases
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Dwarfism
Gonadal Disorders
Hypothalamic Diseases
Musculoskeletal Diseases
Nervous System Diseases
Pituitary Diseases
Interventions listed in this trial
Testosterone plus somatropin
testosterone
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone 17 beta-cypionate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Back to top of Main Content
